4-168878150-TCGCCCC-T
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BS2
The ENST00000505667.6(PALLD):c.1965-12761_1965-12756delCCCGCC variant causes a intron change. The variant allele was found at a frequency of 0.00007 in 1,486,674 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000087 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000068 ( 0 hom. )
Consequence
PALLD
ENST00000505667.6 intron
ENST00000505667.6 intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.33
Publications
0 publications found
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BS2
High AC in GnomAd4 at 13 AD gene.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000505667.6. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PALLD | NM_001166108.2 | MANE Select | c.1965-12761_1965-12756delCCCGCC | intron | N/A | NP_001159580.1 | |||
| PALLD | NM_001166110.2 | c.270_275delCCCGCC | p.Pro91_Pro92del | disruptive_inframe_deletion | Exon 2 of 12 | NP_001159582.1 | |||
| PALLD | NM_016081.4 | c.1965-12761_1965-12756delCCCGCC | intron | N/A | NP_057165.3 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PALLD | ENST00000507735.6 | TSL:1 | c.270_275delCCCGCC | p.Pro91_Pro92del | disruptive_inframe_deletion | Exon 2 of 12 | ENSP00000424016.1 | ||
| PALLD | ENST00000505667.6 | TSL:1 MANE Select | c.1965-12761_1965-12756delCCCGCC | intron | N/A | ENSP00000425556.1 | |||
| PALLD | ENST00000261509.10 | TSL:1 | c.1965-12761_1965-12756delCCCGCC | intron | N/A | ENSP00000261509.6 |
Frequencies
GnomAD3 genomes AF: 0.0000869 AC: 13AN: 149544Hom.: 0 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
13
AN:
149544
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0000890 AC: 8AN: 89912 AF XY: 0.0000988 show subpopulations
GnomAD2 exomes
AF:
AC:
8
AN:
89912
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000681 AC: 91AN: 1337022Hom.: 0 AF XY: 0.0000728 AC XY: 48AN XY: 659012 show subpopulations
GnomAD4 exome
AF:
AC:
91
AN:
1337022
Hom.:
AF XY:
AC XY:
48
AN XY:
659012
show subpopulations
African (AFR)
AF:
AC:
2
AN:
27004
American (AMR)
AF:
AC:
0
AN:
30162
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
23600
East Asian (EAS)
AF:
AC:
0
AN:
30602
South Asian (SAS)
AF:
AC:
2
AN:
74532
European-Finnish (FIN)
AF:
AC:
3
AN:
33152
Middle Eastern (MID)
AF:
AC:
0
AN:
4026
European-Non Finnish (NFE)
AF:
AC:
75
AN:
1058360
Other (OTH)
AF:
AC:
8
AN:
55584
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.575
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0000869 AC: 13AN: 149652Hom.: 0 Cov.: 32 AF XY: 0.0000820 AC XY: 6AN XY: 73164 show subpopulations
GnomAD4 genome
AF:
AC:
13
AN:
149652
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
73164
show subpopulations
African (AFR)
AF:
AC:
2
AN:
40376
American (AMR)
AF:
AC:
2
AN:
15156
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3450
East Asian (EAS)
AF:
AC:
0
AN:
5000
South Asian (SAS)
AF:
AC:
1
AN:
4690
European-Finnish (FIN)
AF:
AC:
0
AN:
10402
Middle Eastern (MID)
AF:
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
AC:
8
AN:
67306
Other (OTH)
AF:
AC:
0
AN:
2086
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.544
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, multiple submitters, no conflicts
Pathogenic
VUS
Benign
Condition
-
1
-
not specified (1)
-
1
-
Pancreatic adenocarcinoma (1)
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.